Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 23 most recent Form 4 transactions.
| Mar 18 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 412 | $50.48 | $20.8K | -2.4% | Open the original filing on SEC.gov |
| Mar 18 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 6,838 | $49.55 | $338.8K | -28.1% | Open the original filing on SEC.gov |
| Mar 18 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 7,250 | $39.40 | $285.7K | +42.5% | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 12,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 22,750 | — | — | — | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 22,290 | $50.73 | $1.1M | -56.7% | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 27,710 | $49.95 | $1.4M | -41.3% | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 15,000 | $38.60 | $579K | +28.8% | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 12,250 | $36.75 | $450.2K | +30.8% | Open the original filing on SEC.gov |
| Mar 17 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 22,750 | $39.40 | $896.4K | +133.5% | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 18,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 22,750 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 15,886 | $50.49 | $802.1K | -48.2% | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 34,114 | $50.18 | $1.7M | -50.9% | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 5,000 | $27.94 | $139.7K | +8.1% | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 18,000 | $32.20 | $579.6K | +40.9% | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 4,250 | $29.61 | $125.8K | +10.7% | Open the original filing on SEC.gov |
| Mar 16 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 22,750 | $36.75 | $836.1K | +133.5% | Open the original filing on SEC.gov |